期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 191, 期 1-2, 页码 70-78出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2007.09.018
关键词
multiple sclerosis; Tr1 regulatory T cells; IL-10; CD46
资金
- NIAID NIH HHS [P01 AI039671-05, P01 AI039671] Funding Source: Medline
- NINDS NIH HHS [P01 NS038037, R01 NS024247-10A2, R01 NS024247, P01 NS038037-01A10003] Funding Source: Medline
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). In the recent years, accumulating evidence has supported an immunosuppressive role for regulatory T cells (Tregs). Most studies in the context of autoimmunity have focused on the defects of the CD4(+)CD25(high) Tregs. However, we recently demonstrated an altered function of Tr1 Treg cells in MS, characterized by a lack of IL-10 secretion. Therefore, several major regulatory T cell defects are involved in human autoimmune disease. Hence, the induction of Tregs or the stimulation of Treg activity may be beneficial for the treatment of such diseases. (c) 2007 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据